201
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The Population Prevalence, Associations of Congenital Heart Defect and Mortality Risk for Down’s Syndrome in South Korea Based on National Health Insurance Service (NHIS) Data

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 519-525 | Published online: 27 May 2020

References

  • Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995;33(1):54–56.7707939
  • Plaiasu V. Down syndrome - genetics and cardiogenetics. Maedica. 2017;12(3):208–213.29218069
  • Chapman RS, Hesketh LJ. Behavioral phenotype of individuals with down syndrome. Ment Retard Dev Disabil Res Rev. 2000;6(2):84–95. doi:10.1002/1098-2779(2000)6:2<84::Aid-mrdd2>3.0.Co;2-p10899801
  • Vis JC, Duffels MG, Winter MM, et al. Down syndrome: a cardiovascular perspective. J Intellect Disabil Res. 2009;53(5):419–425. doi:10.1111/j.1365-2788.2009.01158.x19228275
  • Do C, Xing Z, Yu YE, Tycko B. Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from down syndrome and mouse models. Epigenomics. 2017;9(2):189–207. doi:10.2217/epi-2016-013827911079
  • Cheol Seong S, Kim YY, Khang YH, et al. Data resource profile: the national health information database of the national health insurance service in South Korea. Int J Epidemiol. 2017;46(3):799–800. doi:10.1093/ije/dyw25327794523
  • Kim HS, Lyoo CH, Lee PH, et al. Current status of Huntington’s disease in Korea: a nationwide survey and national registry analysis. J Mov Disord. 2015;8(1):14–20. doi:10.14802/jmd.1403825614781
  • Song SO, Jung CH, Song YD, et al. Background and data configuration process of a nationwide population-based study using the Korean national health insurance system. Diabetes Metab J. 2014;38(5):395–403. doi:10.4093/dmj.2014.38.5.39525349827
  • Service NHI. Research Report on Health Care Utilization of Patients with Rare and Intractable Disorder and Improvement of Individual Copayment Beneficiaries Program for Rare and Intractable Disorder. Wonju: National Health Insurance Service; 2010. doi:10.1097/mib.0000000000000313
  • Wu J, Morris JK. The population prevalence of down’s syndrome in England and Wales in 2011. Eur J Hum Genet. 2013;21(9):1016–1019. doi:10.1038/ejhg.2012.29423321618
  • Alexander M, Ding Y, Foskett N, Petri H, Wandel C, Khwaja O. Population prevalence of down’s syndrome in the United Kingdom. J Intellect Disabil Res. 2016;60(9):874–878. doi:10.1111/jir.1227727018385
  • Presson AP, Partyka G, Jensen KM, et al. Current estimate of down syndrome population prevalence in the United States. J Pediatr. 2013;163(4):1163–1168. doi:10.1016/j.jpeds.2013.06.01323885965
  • Wu J, Morris JK. Trends in maternal age distribution and the live birth prevalence of Down’s syndrome in England and Wales: 1938–2010. Eur J Hum Genet. 2013;21(9):943–947. doi:10.1038/ejhg.2012.28823361224
  • Kim MA, Lee YS, Yee NH, Choi JS, Choi JY, Seo K. Prevalence of congenital heart defects associated with down syndrome in Korea. J Korean Med Sci. 2014;29(11):1544–1549. doi:10.3346/jkms.2014.29.11.154425408587
  • Kim MA, Yee NH, Choi JS, Choi JY, Seo K. Prevalence of birth defects in Korean livebirths, 2005–2006. J Korean Med Sci. 2012;27(10):1233–1240. doi:10.3346/jkms.2012.27.10.123323091323
  • Franasiak JM, Olcha M, Shastri S, et al. Embryonic aneuploidy does not differ among genetic ancestry according to continental origin as determined by ancestry informative markers. Hum Reprod. 2016;31(10):2391–2395. doi:10.1093/humrep/dew19527591228
  • Kim SH, Kim KW, Han YJ, et al. Korean physicians’ attitudes toward the prenatal screening for fetal aneuploidy and implementation of non-invasive prenatal testing with cell-free fetal DNA. Lung Cancer. 2018;143. doi:10.5734/JGM.2018.15.2.72
  • Wikipedia. Abortion in South Korea. Wikimedia Foundation, Inc. [ Updated January 12, 2020]. Available from: https://en.wikipedia.org/wiki/Abortion_in_South_Korea#cite_note-:0-2. Accessed 421, 2020.
  • Lee SY, Byoun SJ, Kim JH, et al. Artificial Abortion Survey. Korea: Korea Institute for Health And Social Affairs; 2018.
  • Zhu JL, Hasle H, Correa A, et al. Survival among people with down syndrome: a nationwide population-based study in Denmark. Genet Med. 2013;15(1):64–69. doi:10.1038/gim.2012.9322878506
  • Englund A, Jonsson B, Zander CS, Gustafsson J, Anneren G. Changes in mortality and causes of death in the Swedish down syndrome population. Am J Med Genet A. 2013;161a(4):642–649. doi:10.1002/ajmg.a.3570623436430
  • Centers for Disease Control and Prevention (CDC). Racial disparities in median age at death of persons with down syndrome–United States, 1968–1997. MMWR Morb Mortal Wkly Rep. 2001;50(22):463–465. Published 2001/06/21.11414598
  • Pueschel SM, Anneren G, Durlach R, Flores J, Sustrova M, Verma IC. Guidelines for optimal medical care of persons with down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH). Acta Paediatr. 1995;84(7):823–827. doi:10.1111/j.1651-2227.1995.tb13768.x7549308
  • Sawatari H, Chishaki A, Nishizaka M, et al. A nationwide cross-sectional study on congenital heart diseases and symptoms of sleep-disordered breathing among Japanese Down’s syndrome people. Intern Med. 2015;54(9):1003–1008. doi:10.2169/internalmedicine.54.398925948338
  • Freeman SB, Taft LF, Dooley KJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 1998;80(3):213–217. doi:10.1002/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-89843040
  • Wu H, Kao SC, Barrientos T, et al. Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development. J Biol Chem. 2007;282(42):30673–30679. doi:10.1074/jbc.M70362220017693409
  • Maslen CL, Babcock D, Robinson SW, et al. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet A. 2006;140(22):2501–2505. doi:10.1002/ajmg.a.3149417036335
  • Wang L, Li Z, Song X, Liu L, Su G, Cui Y. Bioinformatic analysis of genes and MicroRNAs associated with atrioventricular septal defect in Down syndrome patients. Int Heart J. 2016;57(4):490–495. doi:10.1536/ihj.15-31927396555
  • Izzo A, Manco R, de Cristofaro T, et al. Overexpression of chromosome 21 miRNAs may affect mitochondrial function in the hearts of Down syndrome fetuses. Int J Genomics. 2017;2017:8737649. doi:10.1155/2017/873764929057256